[Cardiovascular protection in diabetic patients with heart disease in the doctor's office].
The long-term care of diabetic patients with heart disease poses a particular challenge. Various combinations of risk factors, progression of the coronary heart disease, and complications with further organic damage by the underlying diabetes, frequently necessitate a differentiated diagnostic work-up and management. This can be implemented only by close cooperation between the various specialities. Structured processes may be useful provided they are correctly applied and implemented. Guideline-based treatment of detected cardiovascular risk factors can improve quality of life, reduce morbidity and cardiovascular mortality and thus save costs over the long term.
Eckert
S
S
Herz- und Diabeteszentrum Nordrhein-Westfalen, Universitätsklinik der Ruhr-Universität Bochum, Bad Oeynhausen. seckert@hdz-nrw.de
Tschöpe
D
D
D000368:Aged; D001786:Blood Glucose / Q000032:analysis; D002318:Cardiovascular Diseases / Q000401:mortality / Q000517:prevention & control*; D002784:Cholesterol / Q000097:blood; D003327:Coronary Disease / Q000150:complications / Q000628:therapy*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications / Q000178:diet therapy / Q000188:drug therapy / Q000628:therapy*; D050171:Dyslipidemias / Q000188:drug therapy; D005260:Female; D006333:Heart Failure / Q000628:therapy; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D008019:Life Style; D008297:Male; D024821:Metabolic Syndrome / Q000097:blood / Q000175:diagnosis / Q000517:prevention & control*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011788:Quality of Life; D012307:Risk Factors; D013997:Time Factors
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D010975:Platelet Aggregation Inhibitors; D002784:Cholesterol